Tech Company Financing Transactions

Portal Biotech Funding Round

Earlybird Venture Capital, NATO Innovation Fund (NIF) and 8VC invested in a $35 million Series A funding round for Portal Biotech. The funding round was announced on 6/30/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

58 Wood Lane, Scale Space
London, W12 7RZ
UK

Phone

Undisclosed

Website

www.portalbiotech.com

Email Address

Not Recorded

Overview

Portal's instruments are available today through the protein characterisation services provided by our laboratories. We welcome opportunities for collaboration. Interested commercial or academic parties can also sign up for our Early Access Programme. Portal's technology would not be possible without the incredible talent of our scientists, engineers and technicians. Supporting them is Portal's executive team, who have over 50 years' combined experience in biosensors and nanopore science.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Andy Heron

        

Browse more venture capital transactions:

Prev: 6/30/2025: Skarbe venture capital transaction
Next: 6/30/2025: Manta venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary